Bristol-Myers Squibb to close Irish plant


Bristol-Myers Squibb (BMS) is to close its manufacturing plant in Cruiserath, Ireland, with the loss of 130 jobs by the end of 2015. A further 30 positions will be cut at the nearby plant in Swords as one of several operating units on that site is also shuttered.

BMS tied the closures to ‘changing market demand’ for its products, along with efforts to optimise its manufacturing network. The remaining 320 employees at the Swords plant will continue to manufacture bulk pharmaceuticals.

Susan Hynes, BMS’s general manager of active pharmaceutical ingredient operations Ireland, said in a statement that ‘the company is working to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland’.


Related Content

BMS sells OTC drugs for $482m

14 February 2013 Business

news image

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser

Amylin headquarters to close with further job losses

4 April 2013 Business

news image

Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger

Most Read

Quintuple bond activates small stable molecules

19 September 2014 Research

news image

Exotic complexes suggest route to synthetic feedstock

Computer simulations point to formamide as prebiotic intermediate in ‘Miller’ mixtures

16 September 2014 News and Analysis

news image

Electric field may have provided more than just energy for primordial chemistry

Most Commented

US genomics lead being lost to China

17 September 2014 News and Analysis

news image

NIH senior leaders are sounding the alarm bells, saying the US's pre-eminence in genomics research is under threat

The trouble with boycotts

29 August 2014 Critical Point

news image

Cutting academic ties with a censured state can do more harm than good, says Mark Peplow